Endocrinology, Vol 137, 2791-2798, Copyright © 1996 by Endocrine Society

ARTICLES

Signaling mechanisms underlying the insulinotropic effect of pituitary adenylate cyclase-activating polypeptide in HIT-T15 cells

KA Klinteberg, S Karlsson and B Ahren
Department of Medicine, Lund University, Malmo, Sweden.

The signaling mechanisms underlying the insulinotropic effect of the pancreatic neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) were studied in insulin-producing HIT-T15 cells. It was found that unlabeled PACAP38 dose-dependently displaced [125I]PACAP27 from HIT-T15 cell membranes, showing binding of the peptide to these cells. Furthermore, at levels above 0.1 nM, PACAP38 stimulated insulin secretion in a Ca2+ -dependent manner, requiring 0.5 mM glucose. The peptide also markedly increased the cellular cAMP content and slightly stimulated the formation of inositol phosphates. Moreover, PACAP38 elevated the cytoplasmic Ca2+ concentration ([Ca2+]cyt) in fura-2-AM-loaded cell suspensions. The PACAP38-induced increase in cellular cAMP content was also seen at zero glucose, whereas the increases in insulin secretion and [Ca2+]cyt were abolished by removal of glucose or extracellular Ca2+. We conclude that PACAP38 binds to HIT-T15 cell membranes and acts in a glucose-dependent manner on adenylate cyclase to form cAMP, which both directly and indirectly, through increased [Ca2+]cyt, stimulates exocytosis.

This article has been cited by other articles:

				S. Seino and T. Shibasaki PKA-Dependent and PKA-Independent Pathways for cAMP-Regulated Exocytosis Physiol Rev, October 1, 2005; 85(4): 1303 - 1342. [Abstract] [Full Text] [PDF]

				S. Tomimoto, H. Hashimoto, N. Shintani, K. Yamamoto, Y. Kawabata, K.-I. Hamagami, K. Yamagata, J.-I. Miyagawa, and A. Baba Overexpression of Pituitary Adenylate Cyclase-Activating Polypeptide in Islets Inhibits Hyperinsulinemia and Islet Hyperplasia in Agouti Yellow Mice J. Pharmacol. Exp. Ther., May 1, 2004; 309(2): 796 - 803. [Abstract] [Full Text] [PDF]

				L. Akesson, B. Ahren, V. C. Manganiello, L. S. Holst, G. Edgren, and E. Degerman Dual Effects of Pituitary Adenylate Cyclase-Activating Polypeptide and Isoproterenol on Lipid Metabolism and Signaling in Primary Rat Adipocytes Endocrinology, December 1, 2003; 144(12): 5293 - 5299. [Abstract] [Full Text] [PDF]

				F. Jamen, R. Puech, J. Bockaert, P. Brabet, and G. Bertrand Pituitary Adenylate Cyclase-Activating Polypeptide Receptors Mediating Insulin Secretion in Rodent Pancreatic Islets Are Coupled to Adenylate Cyclase But Not to PLC Endocrinology, April 1, 2002; 143(4): 1253 - 1259. [Abstract] [Full Text] [PDF]

				G. Pacini, K. Thomaseth, and B. Ahren Contribution to glucose tolerance of insulin-independent vs. insulin-dependent mechanisms in mice Am J Physiol Endocrinol Metab, October 1, 2001; 281(4): E693 - E703. [Abstract] [Full Text] [PDF]

				K. Filipsson, M. Kvist-Reimer, and B. Ahren The Neuropeptide Pituitary Adenylate Cyclase-Activating Polypeptide and Islet Function Diabetes, September 1, 2001; 50(9): 1959 - 1969. [Abstract] [Full Text] [PDF]

				B. AHREN and K. FILIPSSON The Effects of PACAP on Insulin Secretion and Glucose Disposal Are Altered by Adrenalectomy in Mice Ann. N.Y. Acad. Sci., December 1, 2000; 921(1): 251 - 258. [Abstract] [Full Text] [PDF]

				K. FILIPSSON and B. AHREN PACAP27 Sensitizes Glucose Induced Insulin Secretion in INS-1 Cells Ann. N.Y. Acad. Sci., December 1, 2000; 921(1): 456 - 459. [Full Text] [PDF]

				K. Filipsson, J. J. Holst, and B. Ahren PACAP contributes to insulin secretion after gastric glucose gavage in mice Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2000; 279(2): R424 - R432. [Abstract] [Full Text] [PDF]

				P. Borboni, O. Porzio, D. Pierucci, S. Cicconi, R. Magnaterra, M. Federici, G. Sesti, D. Lauro, V. D’Agata, S. Cavallaro, et al. Molecular and Functional Characterization of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP-38)/Vasoactive Intestinal Polypeptide Receptors in Pancreatic {beta}-Cells and Effects of PACAP-38 on Components of the Insulin Secretory System Endocrinology, December 1, 1999; 140(12): 5530 - 5537. [Abstract] [Full Text]

				B. Ahren and P. J. Havel Leptin inhibits insulin secretion induced by cellular cAMP in a pancreatic B cell line (INS-1 cells) Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1999; 277(4): R959 - R966. [Abstract] [Full Text] [PDF]

				A. Astesano, K. Regnauld, N. Ferrand, D. Gingras, M. Bendayan, G. Rosselin, and S. Emami Cellular and Subcellular Expression of Golf/Gs and Gq/G11 {alpha}-Subunits in Rat Pancreatic Endocrine Cells J. Histochem. Cytochem., March 1, 1999; 47(3): 289 - 302. [Abstract] [Full Text]

				K. FILIPSSON and B. AHREN Protein Kinase A Inhibition and PACAP-Induced Insulin Secretion in HIT-T15 Cells Ann. N.Y. Acad. Sci., December 11, 1998; 865(1): 441 - 444. [Full Text] [PDF]

				B. AHREN and K. FILIPSSON Pituitary Adenylate Cyclase Activating Polypeptide Stimulates Insulin Secretion in a Glucose-Dependent Manner In Vivo Ann. N.Y. Acad. Sci., December 11, 1998; 865(1): 466 - 470. [Full Text] [PDF]

				K. Filipsson, S. Karlsson, and B. Ahren Evidence for Contribution by Increased Cytoplasmic Na+ to the Insulinotropic Action of PACAP38 in HIT-T15 Cells J. Biol. Chem., December 4, 1998; 273(49): 32602 - 32607. [Abstract] [Full Text] [PDF]

				P. M. Jones and S. J. Persaud Protein Kinases, Protein Phosphorylation, and the Regulation of Insulin Secretion from Pancreatic {beta}-Cells. Endocr. Rev., August 1, 1998; 19(4): 429 - 461. [Abstract] [Full Text] [PDF]

				K. Filipsson, G. Pacini, A. J. W. Scheurink, and B. Ahren PACAP stimulates insulin secretion but inhibits insulin sensitivity in mice Am J Physiol Endocrinol Metab, May 1, 1998; 274(5): E834 - E842. [Abstract] [Full Text] [PDF]

				K. Filipsson, K. Tornoe, J. Holst, and B. Ahren Pituitary Adenylate Cyclase-Activating Polypeptide Stimulates Insulin and Glucagon Secretion in Humans J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 3093 - 3098. [Abstract] [Full Text] [PDF]